Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.070
-0.040 (-3.60%)
Aug 1, 2025, 4:00 PM - Market closed
Opus Genetics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Opus Genetics stock have a consensus rating of "Strong Buy" and an average price target of $6.33, which forecasts a 491.59% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $8.00.
Price Target: $6.33 (+491.59%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 27, 2025.
Analyst Ratings
The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +647.66% | Jun 27, 2025 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +367.29% | Jun 17, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +460.75% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +647.66% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +647.66% | Feb 19, 2025 |
Financial Forecast
Revenue This Year
17.10M
from 10.99M
Increased by 55.59%
Revenue Next Year
28.10M
from 17.10M
Increased by 64.30%
EPS This Year
-0.86
from -2.15
EPS Next Year
-0.54
from -0.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.2M | 31.5M | 45.1M | ||
| Avg | 17.1M | 28.1M | 20.5M | ||
| Low | 15.4M | 25.0M | 5.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 74.8% | 84.2% | 60.3% | ||
| Avg | 55.6% | 64.3% | -26.9% | ||
| Low | 39.7% | 45.9% | -82.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.81 | -0.46 | -0.40 | ||
| Avg | -0.86 | -0.54 | -0.58 | ||
| Low | -0.97 | -0.70 | -0.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.